天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Shanghai Aladdin Biochemical Technology Co.,Ltd.??? ?? ??? ?????.

?? ?:Shanghai Aladdin Biochemical Technology Co.,Ltd.
??:400-6206333
???:market@aladdin-e.com
??:China
URL: www.aladdin-e.com/
? ?? ?:48461
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

?? ????

Telazorlimab (anti-TNFRSF4)2126777-87-3
Dysprosium(III) trifluoromethanesulfonate139177-62-1C3DyF9O9S3
Bis(hexamethylene)triamine143-23-7C12H29N3
Dehydroepiandrosterone sulfate10,13-???-17-??-3-????-1,2,3,4,7,8,9,11,12,14,15,16-???????????[a]????651-48-9C19H28O5S
Xentuzumab (anti-IGF1)1417158-65-6
Bimagrumab (anti-ACVR2B)1356922-05-8
Meropenem-d61133424-00-6C17H25N3O5S
Imazapic?????104098-48-8C14H17N3O3
IDO-IN-132291164-02-6C26H17F3N4O
Ethyl 2-oxo-4-phenylbutyrate64920-29-2C12H14O3
Ranibizumab (anti-VEGFA)347396-82-1C11H12N2O2
Nadecnemab (anti-GFRA3)2377679-19-9
Benzyldiphenylphosphine7650-91-1C19H17P
Codrituzumab (anti-GPC3)1365267-33-9
Urelumab (anti-TNFRSF9)934823-49-1
Elotuzumab (anti-SLAMF7)915296-00-3
Quetmolimab (anti-CX3CL1)2084037-83-0
Bexmarilimab (anti-STAB1)2259301-27-2
Narsoplimab (anti-MASP2)2108782-45-0
8-Azahypoxanthine8-???????2683-90-1C4H3N5O
Sirtratumab (anti-SLITRK6)1824663-82-2
Rosmantuzumab (anti-RSPO3)1684393-04-1
Bivatuzumab (anti-CD44v6)214559-60-1
Tamrintamab (anti-DPEP3)2148325-59-9
Cinpanemab (anti-Alpha-synuclein)2094516-02-4
Mogamulizumab (anti-CCR4)1159266-37-1
Alizarin Yellow R sodium salt1718-34-9C13H8N3NaO5
2-(azetidin-1-yl)ethan-1-amine795299-77-3C5H12N2
Tesnatilimab (anti-NKG2D)2242758-08-1
Lacnotuzumab (anti-M-CSF)1831128-32-5
Tesidolumab (anti-Complement C5)1531594-08-7
Galiximab (anti-CD80)????357613-77-5
Idactamab (anti-SLC1A5)2245205-37-0
Apamistamab (anti-PTPRC)2097132-02-8
Ravulizumab (anti-Complement C5)1803171-55-2
Itolizumab (anti-CD6)1116433-11-4
Lumiliximab (anti-FceR2)357613-86-6
Vopratelimab (anti-ICOS)2039148-04-2
KWAR23 (anti-SIRPg)2243227-60-1
Narnatumab (anti-RON)1188275-92-4
Tisotumab (anti-F3)1418628-81-5
Zagotenemab (anti-Tau)2019133-28-7
Vandortuzumab (anti-STEAP1)1557989-52-2
Ladiratuzumab (anti-SLC39A6)1629760-28-6
Concizumab (anti-TFPI)1312299-39-0
Serplulimab (anti-PDCD1)2231029-82-4
Lexatumumab (anti-TNFRSF10B)?????845816-02-6
Vunakizumab (anti-IL-17a)1792181-33-9
Indusatumab (anti-GUCY2C)1497400-26-6
Ulocuplumab (anti-CXCR4)1375830-34-4
Vantictumab (anti-FZD)1345009-45-1
Fulranumab (anti-NGF)902141-80-4
Ianalumab (anti-TNFRSF13C)1929549-92-7
Gevokizumab (anti-IL-1b)??????G21129435-60-4
Pascolizumab (anti-IL-4)331243-22-2
Gemtuzumab (anti-CD33)????220578-59-6
Seribantumab (anti-ERBB3)1334296-12-6
Tarextumab (anti-NOTCH3)1359940-55-8
Zansecimab (anti-ANGPT2)2415205-37-5
Vorsetuzumab (anti-CD70)1165740-62-4
Lemzoparlimab (anti-CD47)2377483-71-9
Flanvotumab (anti-TYRP1)1188277-05-5
Guselkumab (anti-IL-23)1350289-85-8
Sonepcizumab (anti-Sphingosine-1-phosphate)1031360-18-5
Apelin 17 TFAAPELIN???(61-77)(??,?,???,?)???????????217082-57-0C96H156N34O20S
Ixekizumab (anti-CTLA-8)1143503-69-8
Oxelumab (anti-TNFSF4)1186098-83-8
Sirukumab (anti-IL-6)1194585-53-9
Ragifilimab (anti-TNFRSF18)2207590-51-8
Depatuxizumab mafodotin (anti-EGFR)1585973-65-4
Belimumab (anti-TNFSF13B)????356547-88-1
Dostarlimab (anti-PD-1)2022215-59-2
Daclizumab (anti-IL2RA)?????152923-56-3
Tinurilimab (anti-CEACAM6)2226224-30-0
Otilimab (anti-GM-CSF)1638332-55-4
Ocrelizumab (anti-CD20)637334-45-3C19H16N2O5
Rilotumumab (anti-HGF)872514-65-3
Emibetuzumab (anti-MET)1365287-97-3
Enfortumab (anti-NECTIN4)1448664-46-7
Prezalumab (anti-B7-H2)1523164-68-2
Enoblituzumab (anti-CD276)1353485-38-7
Avdoralimab (anti-C5AR1)2226393-85-5
Labetuzumab govitecan (anti-CEACAM5)1469876-18-3
Girentuximab (anti-CA9)916138-87-9
Datopotamab (anti-TROP2)2267989-53-5
Imaprelimab (anti-CD146)2014343-04-3
Abelacimab(anti-Factor XI)2098724-83-3
Dinutuximab (anti-GD2)1363687-32-4
Efalizumab (anti-ITGAL)??????214745-43-4
Carotuximab (anti-CD105)1268714-50-6
Ontamalimab (anti-MADCAM1)2098790-40-8
Brazikumab (anti-IL-23)1610353-18-8
Enokizumab (anti-IL-9)909875-08-7
Eldelumab (anti-CXCL10)946414-98-8
Daxdilimab (anti-ILT7)2245966-28-1
Bermekimab (anti-IL-1a)1401965-15-8
Ponsegromab (anti-GDF15)2368950-15-4
Denintuzumab (anti-CD19)1630074-14-4
Inebilizumab (anti-CD19)1299440-37-1
Eculizumab (anti-Complement C5)219685-50-4
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2019 ? ChemicalBook. All rights reserved